$PETV

A.L. Sarroff Fund, LLC purchased $25K of PETV

A.L. Sarroff Fund, LLC purchased 35,862 shares of PetVivo Holdings, Inc. (PETV) at an average of $0.69 ($0.68–$0.69) across 2 trades over 2026-09-10 to 2026-09-14.

Original reporting
SEC EDGAR · A.L. Sarroff Fund, LLC
Published Sep 15, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PETV
Neutral
low confidence
Mentioned
$PETV
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PETVNeutralLow
01

Why it matters

The transaction is modest and unlikely to affect market perception of PETV.

02

Market read

Limited relevance; only notable for compliance tracking.

03

What to watch

Potential upcoming clinical trial data or partnership not disclosed could make the trade more relevant.

Relevance 4/10Novelty 4/10Timing: filed Sep 15 2026

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the purchase.

Company-level read

Ticker impact

$PETVNeutralLow confidence
Context

A.L. Sarroff Fund, LLC purchased 35,862 shares of PETV at $0.677-$0.689 per share, totaling $24,577.

Expected impact

Minimal short‑term effect; unlikely to move the stock materially.

Evidence & confidence

Purchase amount is under $25k and represents a tiny fraction of float; market typically ignores such micro‑insider trades.

Market effects

No broader sector impact; PETV operates in a niche biotech space.

None

None

Counterpoint

Even small insider purchases can precede larger moves if insider has material non‑public information.

Key entities

  • PetVivo Holdings, Inc.

    Biotech firm listed under ticker PETV.

  • A.L. Sarroff Fund, LLC

    Insider fund holding a 10% ownership stake.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PETVMedAI 8/10

PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform

PetVivo Holdings (OTCQX: PETV) said it agreed to acquire PiezoBioMembrane (PBM) via a merger, with PBM becoming a wholly owned subsidiary of Cosmeta Corp. PetVivo will issue 3,000,000 shares to PBM shareholders, with some consideration tied to milestones. The company expects PBM’s functional biomaterials and piezoelectric tech to expand IP and product development; closing is subject to customary conditions.